Aspiro Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ASPIRO, and what generic and branded alternatives to ASPIRO drugs are available?
ASPIRO has fifteen approved drugs.
Drugs and US Patents for Aspiro
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aspiro | DAPTOMYCIN | daptomycin | POWDER;INTRAVENOUS | 216413-001 | Sep 23, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aspiro | PANTOPRAZOLE SODIUM | pantoprazole sodium | INJECTABLE;INTRAVENOUS | 213778-001 | May 18, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aspiro | BUPIVACAINE HYDROCHLORIDE | bupivacaine hydrochloride | INJECTABLE;INJECTION | 217821-003 | Mar 27, 2024 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aspiro | KETOROLAC TROMETHAMINE | ketorolac tromethamine | INJECTABLE;INJECTION | 217166-002 | Jun 20, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aspiro | BUPIVACAINE HYDROCHLORIDE | bupivacaine hydrochloride | INJECTABLE;INJECTION | 217821-002 | Mar 27, 2024 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aspiro | SUGAMMADEX SODIUM | sugammadex sodium | SOLUTION;INTRAVENOUS | 214337-001 | Jun 9, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.